1st Annual European Healthcare Impact Summit

1st Annual European Healthcare Impact Summit

Incorporating 13th HealthTech Investment Forum & 8th HealthTech Innovation Days

6th of October 2026|MÖVENPICK HOTEL BASEL | SWITZERLAND

We are pleased to announce that the 1st Annual European Healthcare Impact Summit (#Sachs_EHIS) will take place on the 6th of October 2026 at the Mövenpick Hotel Basel. The event will be part of the Sachs Autumn Life Sciences Week (#SALSW), which will also incorporate the 26th Annual Biotech in Europe Forum (#Sachs_BEF).
​
The EHIS will replace the 13th Annual HealthTech Investment Forum (#Sachs_HTIF), previously hosted in Basel, and the 8th Annual HealthTech Innovation Days (HTID), previously hosted in Paris. It will continue HTID’s tradition of hosting a high-profile October summit, advancing discussions across the European healthcare ecosystem, and bringing innovative solutions to patients. The programme will highlight European world-leading innovation across multiple medical fields, including orphan diseases.

The physical programme will consist of panels and keynotes/workshops, which will be available on-demand by the 15th of October. Additionally, there will be pre-arranged in-person meetings, live and on-demand company showcases, as well as a networking reception. Recordings of the presentations will be uploaded by the 13th of October. During the Online Partnering Week, virtual meetings will be available through the Online Meeting System. 

We anticipate around 300 delegates attending in-person & virtually, with up to 20 company presentations by established and emerging companies offering innovative solutions, seeking investment, and partnering opportunities. This will include a limited number of live presentations taking place in a dedicated parallel presentation track, alongside virtual company showcases, which will be available on demand. Recorded sessions will also be added on demand on the Event Portal during the virtual week. 

The SALSW brings together a global audience of senior pharma, Biotech, HealthTech, MedTech and digital health executives, alongside bankers, consultants, financial and corporate investors, along with a select number of service providers. The EHIS will focus on the broader healthcare ecosystem, bringing together KOLs, leading healthcare organisations, hospitals, scientists, and life sciences and HealthTech executives. Its programme will highlight innovation across medtech/devices, diagnostics, drug discovery, and digital health.

The in-person meetings will take place during the physical event on the 6th of October, while virtual meetings will be held from the 13th - 15th of October. For virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function, and we will have a dedicated room for in-person meetings. We expect over 2000 meetings to be completed during SALSW. The conference will be held in the Central European Summer Time (CEST) zone. 

BRONZE SPONSORS:

Forvis Mazars
PSCC

CONTRIBUTING SPONSOR:

Covington & Burling LLP

Panels & Sessions on the 6th of October Include:

  • Keynote Speech: "Financing Europe’s Life Sciences Future: The EIB Perspective on Competitiveness, Innovation & Scale"
  • New Initiatives Panel: Strengthening Europe’s Biotech & Life Sciences Investment Outlook
  • Keynote Speech: "Re-Shoring Life Sciences for a Sustainable Future"
  • Keynote Speech: "The Paris Saclay Cancer Cluster: Transforming Science Discoveries into Industrial Solutions"
  • Oncology True Innovation Panel: Building on World-Class Science
  • Pharma-Biotech Partnering in Emerging Technology Platforms Panel
  • Fireside Chat
  • Deep Tech & AI Revolutionizing Drug Discovery & Diagnostics Panel
  • The Next Frontier in Stroke Care Panel: Therapeutics, Devices & Digital Innovation
  • Keynote Speech: "Where Spinal Surgery Meets Pain Management: The Huge Unmet Need"
  • Investment Strategies for Next-Generation MedTech & Devices Panel
  • Concluding Comments

In-Person Meetings:

  • 6th of October

Online Virtual Meetings:

  • 13th – 15th of October

Reception:

  • 6th of October

Keynote Speakers:

Camille Srour
Founder & CEO, SC MEDICA
Cristina Niculescu
Lead Life Sciences Specialist, European Investment Bank
Eric Vivier
President, PSCC
Marc de Garidel
CEO, Abivax SA
Nicolas Quairel
Global Lifescience Consulting Lead Partner, Forvis Mazars
Pierre Courteille
Chief Business Officer, Abivax SA
Sam Fazeli
Head of Research, Global Industries & Senior Pharmaceuticals Analyst, Bloomberg Intelligence

Chairs & Speakers:

Barbara Castellano
Partner, Panakès Partners SGR SpA
Barbara Lueckel
Global Head of Research Technologies Partnering, F. Hoffmann-La Roche AG
Catherine Thieblemont
Professor, Gustave Roussy
Cem Baydar
Chief Investment Officer & Board Member, Afendis Capital Management
Chris Church
Head of Technology Search & Evaluation, BD&L, AstraZeneca
Christian Kannemeier
Senior Investment Manager, High-Tech Gründerfonds Management GmbH
Christophe Chautems
Co-Founder & Board Member, Nanoflex Robotics AG
Domitille Halie
Director, Programs & Accounts, Bioproduction, WhiteLab Genomics
Esteban Pombo-Villar
Board Member, TargImmune Therapeutics AG
Eyal Lifschitz
Co-Founder & General Managing Partner, Peregrine Ventures
Florent Gros
Partner, Earlybird Health Management GmbH & Co. KG
Gabriel Coffin
Data Director, PSCC
Gargi Patel
VP Oncology Clinical Development, GSK
James Halstead
Partner, Covington & Burling LLP
Karsten Miermans
Founder & CEO, hema.to GmbH
Katrin Vatiska
Investment Partner, MTIP AG
Kelly Curtin
Managing Director, Stifel
Khatereh Ahmadi
Venture Partner, XGEN Venture SGR S.p.A.
Lloyd Diamond
CEO, Nitinotes Ltd.
Marc Dechamps
CEO, Bioxodes SA
Michalis Papadakis
Co-Founder & CEO, Brainomix Limited
Miro Venturi
Operating Partner & Executive, ARCHIMED
Naftali Cohen
Co-Founder & CBO, NucleoTech Inc.
Nick Dunster
Senior Investment Manager, European Investment Fund
Olivier Huillard
Co-Founder of Areltys & Medical Oncologist, AP-HP (Greater Paris University Hospitals)
Paulius Viskaitis
Co-Founder & CEO, Skaaltec AG
Philippe Monteyne
Senior Advisor, AltamarCAM Partners
Rainer Strohmenger
Managing Partner, Wellington Partners
Ricardo Gaminha Pacheco
Longevity Biotechnology Strategic Partnering, BD&L Director, Insilico Medicine
Roby Kanichay
VP, GBD - Head of Technologies and Externalizations, Merck KGaA
Sabin Minguez
Senior Director, R&D Business Development, GSK
Sandra von Meier
Head of Business Development Life Science, Terra Quantum AG
Sarah Holland
President of Swiss Healthcare Licensing Group & CBO, CDR-Life, Inc.
Thomas Thestrup
Managing Director, Fresenius Ventures
Ulrich Muehlner
Co-Founder & CEO, docdok.health Ltd.

Presenting Companies:

Brainomix Limited logo
GreenBone Ortho S.p.A. logo
hema.to GmbH logo
iniuva GmbH logo
LIMAA Technologies GmbH logo
NGScopes GmbH logo
Nitinotes Ltd. logo

Previous Highlights:

1st Annual European Healthcare Impact Summit event highlight
1st Annual European Healthcare Impact Summit event highlight
1st Annual European Healthcare Impact Summit event highlight
1st Annual European Healthcare Impact Summit event highlight
1st Annual European Healthcare Impact Summit event highlight

To learn more about presenting, exhibiting or sponsorship opportunities, please contact us at [email protected] or call us on + 44 203 463 4890.

SACHS ASSOCIATES SWITZERLAND AG

Aeschenvorstadt 4
Basel | CH-4051
Switzerland

SACHS ASSOCIATES LTD.

3rd floor, 89-90 Paul Street
London | EC2A 4NE
United Kingdom
Privacy Policy

© COPYRIGHT 2026. ALL RIGHTS RESERVED.